Personalizing Radiation Treatment Delivery in the Management of Breast Cancer
Long-term data establishes the efficacy of radiotherapy in the adjuvant management of breast cancer. New dose and fractionation schemas have evolved and are available, each with unique risks and rewards. Current efforts are ongoing to tailor radiotherapy to the unique biology of breast cancer. In th...
Main Authors: | Kamran A. Ahmed, G. Daniel Grass, Amber G. Orman, Casey Liveringhouse, Michael E. Montejo, Hatem H. Soliman, Heather S. Han, Brian J. Czerniecki, Javier F. Torres-Roca, Roberto Diaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2018/6729802 |
Similar Items
-
Utilizing the genomically adjusted radiation dose (GARD) to personalize adjuvant radiotherapy in triple negative breast cancer managementResearch in context
by: Kamran A. Ahmed, et al.
Published: (2019-09-01) -
Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions
by: Casey L. Liveringhouse, MD, et al.
Published: (2021-07-01) -
Capecitabine and stereotactic radiation in the management of breast cancer brain metastases
by: Matthew N. Mills, et al.
Published: (2021-05-01) -
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases
by: Matthew N. Mills, et al.
Published: (2021-03-01) -
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
by: Jan Poleszczuk, et al.
Published: (2017-06-01)